地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：13212737804
传真：15172431432
邮箱：sales@amyjet.com
瑞典Agrisera公司成立于1980年，长期以来，公司致力于植物/环境科学研究中所需蛋白抗体研发与销售，主要集中于模式之物及其他植物的生理、病理相关的蛋白抗体。Agrisera 公司以提供高品质、优服务在欧洲树立了优秀的品牌形象，并成为瑞典 Umeå Plant Science Centre的抗体供货商，同时还积极拓展全球市场，每年都有大批采用该公司抗体产品的高质量研究论文发表于各类学术刊物，受到全球科研工作者的一致认可。Agrisera的所有抗体分两大类：植物及藻类的抗体，以及细菌、真菌、昆虫、鱼等动物类抗体，植物领域的抗体涵盖Arabidopsis thaliana、Hordeum vulgare、Chlamydomonas reinhardtii、Cyanobacteria、Physcomitrella patens、Oryza sativa、Populus sp、Conifers等多个物种。
Agrisera is a Swedish company specializing in polyclonal and monoclonal antibody production, offering an extensive collection of primary antibodies and over 2000 secondary antibodies for various applications and in various quantities, all available online. Over 30 years in the antibody business have taught us a lot and we are proud to say there are few problems we cannot help you to solve. Our experienced scientific staff are on hand to answer all your queries promptly.
Agrisera公司的主要产品包括：
Plant/Algal antibodies
Animal/Human antibodies
Bacterial/Fungal antibodies
Secondary antibodies
Rapid Western Blotting
Detection reagents
" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Agrisera"> Agrisera
Swant专注于钙结合蛋白相关产品的研发和销售，产品包括：钙结合蛋白抗体、纯化的重组蛋白、钙离子通道和钙泵抗体以及其他抗体和ELISA。
Antibodies to Calbindin D-28k, Calretinin, Parvalbumin, Calmodulin and to Na2+-Ca2+-exchangers, Ca2+ pumps, neurotransmitters, as well as their respective antigens. Superb staining of subpopulation of neurons or glial cells in various species, including humans. Selective staining of various types of cancers. Our mono- and polyclonal antibodies are of high titer and of high specificity. They can be used in immunohistochemistry and immunoblots at dilution of more than 1:5'000 (Avidin-Biotin-Method). The recombinant antigens have been purified by HPLC and FPLC. The products are supplied in lyophilized form and are accompanied by detailed product description as well as by a method sheet.
Swant 的主要产品包括：
（1）Antibodies against Ca2+ - binding proteins
Calbindin
Calretinin
Parvalbumin
Others
（2）Purified and recombinant proteins
Calbindin
Calretinin
Parvalbumin
Others
（3）Antibodies against Ca2+ exchangers and Ca2+ pumps
Ca2+ - exchangers
Ca2+ - pumps
（4）Various
Antibodies against insulin-like growth factors
Antibodies against neurotransmitters
Antibodies against components of the renin-angiotensin system
Miscellaneous antibodies
（5）ELISA KITS
Sandwich-ELISA
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
< " data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Swant"> Swant
Premetek公司致力于为学术客户和工业客户提供化学试剂、纳米材料和催化剂，同时也提供多领域的研发服务。通过不断地与业内专业企业进行技术整合，Premetek不断更新产品，并为材料科学和催化领域提供了最多样化和可扩展的选择。
Our retail objectives are to offer the most expansive selection of premium products, provide easy and friendly service, offer the fastest delivery time possible, and ensure that every customer is satisfied with their purchase. Our inventory is determined by extensive market research, attendance at international tradeshows and conferences, customer feedback, and working closely with industry experts and vendors. Premetek is committed to continually improving our services and being the premier online market place for all your needs.
Premetek公司的主要产品包括：
Nanomaterials
Nanomaterial Suspension
Pt,Pd Catalysts -Hydrogenation
Pt,Pd Catalysts -Red/Oxidation
Pt Catalysts - Electrochemistry
Pt Alloy Catalysts - Electrochemistry
Pd Alloy Catalysts - Electrochemistry
Pd,Ru,Ir,Rh,Au Catalysts - Electrochemistry
Fe,Co,Ni,Cu,Ag Catalysts - Electrochemistry
Pt,Pd,Ru,Ir,Rh,Au-Organometallics
Pt, Pd, Rh Homogeneous Catalysts
Custom Products
Special catalysts in stock
| 品名 | 货号 | 规格 |
| Aluminum titanate, Al2TiO5, 40 g each | N10A1000 | 40g |
| Barium strontium titanium oxide, BaSrTi2O6, 40 g each | N10B2000 | 40g |
| Calcium titanate, CaTiO3, 40 g each | N10C1000 | 40g |
| Calcium zirconium titanium oxide, CaZrTi2O3, 40 g each | N10C2000 | 40g |
| Cadmium tungsten oxide, CdWO4, 40 g each | N10C3000 | 40g |
| Cerium aluminate, CeAlO3, 40 g each | N10C4000 | 40g |
| Copper aluminate, CuAl2O4, 40 g each | N10C5000 | 40g |
| Iron nickel oxide, FeNiO4, 40 g each | N10I1000 | 40g |
| Lanthanum chromite, LaCrO3, 40 g each | N10L1000 | 40g |
| Lanthanum manganite , LaMnO3, 40 g each | N10L3000 | 40g |
| Lanthanum substituted lithium titanate, (LaLi3)TiO3, 40 g each | N10L5000 | 40g |
| Lead zirconium substituted titanate, PbZr0.2Ti0.8O3, 40 g each | N10L6000 | 40g |
| Manganese titanate, MnTiO3, 40 g each | N10M1000 | 40g |
| Magnesium aluminate, MgAl2O4, 40 g each | N10M2000 | 40g |
| Nickel cobalt oxide, NiCoO2, 40 g each | N10N1000 | 40g |
| Strontium bismuth niobium oxide, SrBi2Nb2O9, 50 g each | N10S1000 | 40g |
| Strontium ferrite, SrFe12O19, 40 g each | N10S2000 | 40g |
| Yttrium aluminum oxide, Y3Al5O12, 40 g each | N10Y1000 | 40g |
| Yttrium iron oxide, Y3Fe5O12, 40 g each | N10Y2000 | 40g |
| Zinc iron oxide, ZnFe2O4, 40 g each | N10Z1000 | 40g |
| Zinc titanium oxide, ZnTiO3, 40 g each | N10Z2000 | 40g |
| Concentrated Suspension of Nanoscaled Titanium Dioxide (TiO2), 5 kg | N-1000 | 5kg |
| Concentrated Suspension of Nanoscaled Zinc Oxide (ZnO), 5 kg | N-2000 | 5kg |
| Concentrated Suspension of Nanoscaled Zinc Oxide (ZnO), 5 kg | N-2010 | 5kg |
| Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3000 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3010 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3020 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3130 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3220 | 5kg |
| Concentrated Suspension of Nanoscaled Iron Oxide (Fe2O3), 5 kg | N-3230 | 5kg |
| 0.1% Pt on activated carbon powder, 10 g each | P10J1001 | 10g |
| 0.5% Pt on activated carbon powder, 10 g each | P10J1005 | 10g |
| 1.0% Pt on activated carbon powder, 10 g each | P10J1010 | 10g |
| 5.0% Pt on activated carbon powder, 10 g each | P10J1050 | 10g |
| 10% Pt on activated carbon powder, 10 g each | P10J1100 | 10g |
| 20% Pt on activated carbon powder, 10 g each | P10J1200 | 10g |
| 0.1% Pt on granular carbon, 10 g each | P10J2001 | 10g |
| 0.5% Pt on granular carbon, 10 g each | P10J2005 | 10g |
| 1.0% Pt on granular carbon, 10 g each | P10J2010 | 10g |
| 5.0% Pt on granular carbon, 10 g each | P10J2050 | 10g |
| 0.1% Pd on activated carbon powder, 10 g each | P30J1001 | 10g |
| 0.5% Pd on activated carbon powder, 10 g each | P30J1005 | 10g |
| 1.0% Pd on activated carbon powder, 10 g each | P30J1010 | 10g |
| 5.0% Pd on activated carbon powder, 10 g each | P30J1050 | 10g |
| 10% Pd on activated carbon powder, 10 g each | P30J1100 | 10g |
| 20% Pd on activated carbon powder, 10 g each | P30J1200 | 10g |
| 0.1% Pd on granular carbon, 10 g each | P30J2001 | 10g |
| 0.3% Pd on granular carbon, 10 g each | P30J2003 | 10g |
| 0.5% Pd on granular carbon, 10 g each | P30J2005 | 10g |
| 1.0% Pd on granular carbon, 10 g each | P30J2010 | 10g |
| 5.0% Pd on granular carbon, 10 g each | P30J2050 | 10g |
| 0.5% Pd on alumina spheres, 3 mm, SA= | P30L1005 | 10g |
| 1.0% Pd on alumina spheres, 3 mm, SA= | P30L1010 | 10g |
| 0.1% Pt on alumina powder, 10 g each | P10K1001 | 10g |
| 0.5% Pt on alumina powder, 10 g each | P10K1005 | 10g |
| 1.0% Pt on alumina powder, 10 g each | P10K1010 | 10g |
| 5.0% Pt on alumina powder, 10 g each | P10K1050 | 10g |
| 10% Pt on alumina powder, 10 g each | P10K1100 | 10g |
| 20% Pt on alumina powder, 10 g each | P10K1200 | 10g |
| 0.1% Pd on alumina powder, 10 g each | P30K1001 | 10g |
| 0.5% Pd on alumina powder, 10 g each | P30K1005 | 10g |
| 1.0% Pd on alumina powder, 10 g each | P30K1010 | 10g |
| 5.0% Pd on alumina powder, 10 g each | P30K1050 | 10g |
| 10% Pd on alumina powder, 10 g each | P30K1100 | 10g |
| 20% Pd on alumina powder, 10 g each | P30K1200 | 10g |
| 5% Pt on Vulcan XC-72 | P10A050 | 1g/5g |
| 10% Pt on Vulcan XC-72 | P10A100 | 1g/5g |
| 20% Pt on Vulcan XC-72 | P10A200 | 1g/5g |
| 30% Pt on Vulcan XC-72 | P10A300 | 1g/5g |
| 40% Pt on Vulcan XC-72 | P10A400 | 1g/5g |
| 50% Pt on Vulcan XC-72 | P10A500 | 1g/5g |
| 60% Pt on Vulcan XC-72 | P10A600 | 1g/5g |
| 80% Pt on Vulcan XC-72 | P10A800 | 1g/5g |
| Pt Black, High surface area: 40-50 m2/g, Low density: 0.6-0.9 g/ml | P10V010 | 1g/5g |
| 20% Pt on Durable Carbon | P10D200 | 1g/5g |
| 20% Pt on Vulcan XC-72R | P10B200 | 1g/5g |
| 40% Pt on Vulcan XC-72R | P10B400 | 1g/5g |
| 60% Pt on Vulcan XC-72R | P10B600 | 1g/5g |
| 40% Pt on high surface area Ketjenblack | P10E400 | 1g/5g |
| 50% Pt on high surface area Ketjenblack, | P10E500 | 1g/5g |
| 60% Pt on high surface area Ketjenblack | P10E600 | 1g/5g |
| 70% Pt on high surface area Ketjenblack | P10E700 | 1g/5g |
| 5% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A050 | 1g/5g |
| 10% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A100 | 1g/5g |
| 20% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A200 | 1g/5g |
| 30% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A300 | 1g/5g |
| 40% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A400 | 1g/5g |
| 50% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A500 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72R | P12B600 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A600 | 1g/5g |
| 80% Pt-Ru (1:1 atomic ratio) on Vulcan XC-72 | P12A800 | 1g/5g |
| Pt-Ru Black (1:1 atomic ratio) | P12V010 | 1g/5g |
| Pt-Ru Black (2.5:1 atomic ratio) | P12V250 | 1g/5g |
| Pt-Ru-Ir Black (1:1:1 atomic ratio) | P124V010 | 1g/5g |
| 50% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E500 | 1g/5g |
| 60% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E600 | 1g/5g |
| 75% Pt-Ru (1:1 atomic ratio) on Ketjenblack | P12E750 | 1g/5g |
| 20% Pt-Pd (1:3 atomic ratio) on Vulcan XC-72 | P13A203 | 1g/5g |
| 20% Pt-Pd (1:1 atomic ratio) on Vulcan XC-72 | P13A200 | 1g/5g |
| 20% Pt-Pd (3:1 atomic ratio) on Vulcan XC-72 | P13A230 | 1g/5g |
| 40% Pt-Pd (1:1 atomic ratio) on Vulcan XC-72 | P13A400 | 1g/5g |
| Pt-Pd Black (1:1 atomic ratio) | P13V010 | 1g/5g |
| Pt-Rh Black (1:1 atomic ratio) | P15V010 | 1g/5g |
| 20% Pt-Ir (1:3 atomic ratio) on Vulcan XC-72 | P14A203 | 1g/5g |
| 20% Pt-Ir (1:1 atomic ratio) on Vulcan XC-72 | P14A200 | 1g/5g |
| 20% Pt-Ir (3:1 atomic ratio) on Vulcan XC-72 | P14A230 | 1g/5g |
| 40% Pt-Ir (1:1 atomic ratio) on Vulcan XC-72 | P14A400 | 1g/5g |
| Pt-Ir Black (1:1 atomic ratio) | P14V010 | 1g/5g |
| 20% Pt-Cr (3:1 atomic ratio) on Vulcan XC-72 | P1AA230 | 1g/5g |
| 40% Pt-Cr (3:1 atomic ratio) on Vulcan XC-72 | P1AA430 | 1g/5g |
| 20% Pt-Fe (1:1 atomic ratio) on Vulcan XC-72 | P1BA200 | 1g/5g |
| 40% Pt-Fe (1:1 atomic ratio) on Vulcan XC-72 | P1BA400 | 1g/5g |
| 40% Pt-Fe (3:1 atomic ratio) on Vulcan XC-72 | P1BA430 | 1g/5g |
| 20% Pt-Co (1:1 atomic ratio) on Vulcan XC-72 | P1CA200 | 1g/5g |
| 20% Pt-Co (3:1 atomic ratio) on Vulcan XC-72 | P1CA230 | 1g/5g |
| 40% Pt-Co (1:1 atomic ratio) on Vulcan XC-72 | P1CA400 | 1g/5g |
| 40% Pt-Co (3:1 atomic ratio) on Vulcan XC-72 | P1CA430 | 1g/5g |
| 60% Pt-Co (3:1 atomic ratio) on Ketjenblack | P1CE630 | 1g/5g |
| 20% Pt-Ni (1:1 atomic ratio) on Vulcan XC-72 | P1DA200 | 1g/5g |
| 20% Pt-Ni (3:1 atomic ratio) on Vulcan XC-72 | P1DA230 | 1g/5g |
| 40% Pt-Ni (1:1 atomic ratio) on Vulcan XC-72 | P1DA400 | 1g/5g |
| 40% Pt-Ni (3:1 atomic ratio) on Vulcan XC-72 | P1DA430 | 1g/5g |
| 60% Pt-Ni (3:1 atomic ratio) on Ketjenblack | P1DE630 | 1g/5g |
| 20% Pt-Cu (1:1 atomic ratio) on Vulcan XC-72 | P1EA200 | 1g/5g |
| 20% Pt-Cu (3:1 atomic ratio) on Vulcan XC-72 | P1EA230 | 1g/5g |
| 20% Pt-Sn (3:1 atomic ratio) on Vulcan XC-72 | P1FA230 | 1g/5g |
| 40% Pt-Sn (3:1 atomic ratio) on Vulcan XC-72 | P1FA430 | 1g/5g |
| 20% Pd-Ir (1:3 atomic ratio) on Vulcan XC-72 | P34A203 | 1g/5g |
| 20% Pd-Ir (1:1 atomic ratio) on Vulcan XC-72 | P34A200 | 1g/5g |
| 20% Pd-Ir (3:1 atomic ratio) on Vulcan XC-72 | P34A230 | 1g/5g |
| 20% Pd-Rh (1:1 atomic ratio) on Vulcan XC-72 | P35A200 | 1g/5g |
| 20% Pd-Rh (3:1 atomic ratio) on Vulcan XC-72 | P35A230 | 1g/5g |
| 20% Pd-Ni (1:1 atomic ratio) on Vulcan XC-72 | P3DA200 | 1g/5g |
| 40% Pd-Au (1:1 atomic ratio) on Ketjenblack | P13E400 | 1g/5g |
| 5% Pd on Vulcan XC-72 | P30A050 | 1g/5g |
| 10% Pd on Vulcan XC-72 | P30A100 | 1g/5g |
| 20% Pd on Vulcan XC-72 | P30A200 | 1g/5g |
| 40% Pd on Vulcan XC-72 | P30A400 | 1g/5g |
| 40% Pd on Ketjenblack | P30E400 | 1g/5g |
| 60% Pd on Vulcan XC-72 | P30A600 | 1g/5g |
| 80% Pd on Vulcan XC-72 | P30A800 | 1g/5g |
| Pd Black, High surface area 40~48 m2/g | P30V010 | 1g/5g |
| 20% Ru on Vulcan XC-72 | P20A200 | 1g/5g |
| 40% Ru on Vulcan XC-72, | P20A400 | 1g/5g |
| Ru Black, High surface area 38~48 m2/g | P20V010 | 1g/5g |
| RuO2 powder, Surface area 18-25 m2/g | P20V020 | 1g/5g |
| 5% Ir on Vulcan XC-72 | P40A050 | 1g/5g |
| 10% Ir on Vulcan XC-72 | P40A100 | 1g/5g |
| 20% Ir on Vulcan XC-72 | P40A200 | 1g/5g |
| 40% Ir on Vulcan XC-72 | P40A400 | 1g/5g |
| Ir Black, High Surface area, 55~65 m2/g, | P40V010 | 1g/5g |
| IrOx powder, conductive, SA:10-20 m2/g | P40V020 | 1g/5g |
| Ru-Ir Black (1:1 atomic ratio) | P24V010 | 1g/5g |
| 20% Rh on Vulcan XC-72 | P50A200 | 1g/5g |
| Rh Black, High surface area 40~50 m2/g | P50V010 | 1g/5g |
| 20% Au on Vulcan XC-72 (Au particle size: 4-8 nm) | P60N200 | 1g/5g |
| 20% Au on Vulcan XC-72 (Au particle size: ~25 nm) | P60A200 | 1g/5g |
| 30% Au on Vulcan XC-72 (Au particle size: 8 nm) | P60N300 | 1g/5g |
| 40% Au on Vulcan XC-72 (Au particle size: ~35 nm) | P60A400 | 1g/5g |
| 40% Au on Ketjenblack (Au particle size: 4 nm) | P60E400 | 1g/5g |
| 60% Au on Vulcan XC-72 (Au particle size: ~45 nm) | P60A600 | 1g/5g |
| 5% Fe on Vulcan XC-72 | T10A050 | 1g/5g |
| 10% Fe on Vulcan XC-72 | T10A100 | 1g/5g |
| 20% Fe on Vulcan XC-72 | T10A200 | 1g/5g |
| 1% Co on Vulcan XC-72 | T20A010 | 1g/5g |
| 5% Co on Vulcan XC-72 | T20A050 | 1g/5g |
| 10% Co on Vulcan XC-72 | T20A100 | 1g/5g |
| 20% Co on Vulcan XC-72 | T20A200 | 1g/5g |
| 1% Ni on Vulcan XC-72 | T30A010 | 1g/5g |
| 5% Ni on Vulcan XC-72 | T30A050 | 1g/5g |
| 10% Ni on Vulcan XC-72 | T30A100 | 1g/5g |
| 20% Ni on Vulcan XC-72 | T30A200 | 1g/5g |
| 40% Ni on Vulcan XC-72 | T30A400 | 1g/5g |
| 1% Cu on Vulcan XC-72 | T40A010 | 1g/5g |
| 5% Cu on Vulcan XC-72 | T40A050 | 1g/5g |
| 10% Cu on Vulcan XC-72 | T40A100 | 1g/5g |
| 20% Cu on Vulcan XC-72 | T40A200 | 1g/5g |
| 40% Cu on Vulcan XC-72 | T40A400 | 1g/5g |
| 60% Cu on Vulcan XC-72 | T40A600 | 1g/5g |
| 20% Ag on Vulcan XC-72 | P70A200 | 1g/5g |
| 40% Ag on Vulcan XC-72 | P70A400 | 1g/5g |
| 60% Ag on Vulcan XC-72 | P70A600 | 1g/5g |
| 80% Ag on Vulcan XC-72 | P70A800 | 1g/5g |
| Platinum (II) acetylacetonate, 5 g each | P10H110 | 5g |
| (1,5-Cyclooctadiene)dimethylplatinum(II), 1 g each | P10H120 | 1g |
| Dichloro(1,5-cyclooctadiene)platinum(II), 5 g each | P10H130 | 5g |
| Diphenyl(1,5-cyclooctadiene)platinum(II), 5 g each | P10H140 | 5g |
| Trimethylbenzylammoniumhexachloroplatinate (IV), 1 g each | P10H150 | 1g |
| Palladium(II) acetylacetonate, 5 g each | P30H110 | 5g |
| Dichloro(1,5-cyclooctadiene)palladium(II), 5 g each | P30H120 | 5g |
| Hermann's Catalyst, 5 g each | P30H130 | 5g |
| 1,1'-Bis(di-tert-butylphosphino)ferrocene palladium dichloride, 1 g each | P30H140 | 1g |
| Bis(dibenzylideneacetone)palladium(0), 5 g each | P30H150 | 5g |
| Palladium(0) tetrakis(triphenylphosphine), 5 g each | P30H160 | 5g |
| Ruthenium(III) acetylacetonate, 5 g each | P20H110 | 5g |
| Dichloro(1,5-cyclooctadiene)ruthenium(II), polymer, 5 g each | P20H120 | 5g |
| Bis(cyclopentadienyl)ruthenium, 5 g each | P20H130 | 5g |
| Irridium(III) acetylacetonate, 5 g each | P40H110 | 5g |
| Chloro(1,5-cyclooctadiene)iridium(I) dimer, 5 g each | P40H120 | 5g |
| Rhodium(III) acetylacetonate, 5 g each | P50H110 | 5g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 1 g each | P50H120 | 1g |
| Chloro(triphenylphosphine)gold(I), 5 g each | newitem3 | 5g |
| Bromo(triphenylphosphine)gold(I), 5 g each | P60H110 | 5g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 98% 1 g | P50-002 | 1g |
| Chloro(1,5-cyclooctadiene)rhodium(I) dimer, 98% 1 g | P50-002 | 1g |
| Doyledirhodium catalyst-Rh2(5R-MPPIM)4, 1 g | P50-001 | 1g |
| Doyledirhodium catalyst-Rh2(5S-MPPIM)4, 1 g | P50-003 | 1g |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
Neuromab是一家由NIH资助成立的单克隆抗体库。
The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.
Neuromab的主要产品包括：
Array Tomography
Model Organisms
Disease Targets
产品列表：
| 抗体名称 |
| Anti-5-formylcytidine, NeuroMab clone N358/68 |
| Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59 |
| Anti-6xHis, NeuroMab clone N144/14 |
| Anti-ADAM11, NeuroMab clone N441/35 |
| Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30 |
| Anti-ADAM22-extracellular, NeuroMab clone N57/2 |
| Anti-AGPS neo-epitope, NeuroMab clone N444/63 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39 |
| Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31 |
| Anti-Alg13, NeuroMab clone N442/28 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80 |
| Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51 |
| Anti-AMIGO-1, NeuroMab clone L86/33 |
| Anti-AMIGO-1, NeuroMab clone L86/36 |
| Anti-AMIGO-1, NeuroMab clone L86A/37 |
| Anti-Ankyrin-B, NeuroMab clone N105/13 |
| Anti-Ankyrin-B, NeuroMab clone N105/17 |
| Anti-Ankyrin-G, NeuroMab clone N106/20 |
| Anti-Ankyrin-G, NeuroMab clone N106/36 |
| Anti-Ankyrin-G, NeuroMab clone N106/65 |
| Anti-Ankyrin-G, NeuroMab clone N106/43 |
| Anti-Ankyrin-R, NeuroMab clone N388A/10 |
| Anti-Ankyrin-R/G, NeuroMab clone N388A/27 |
| Anti-ANO3/TMEM16C, NeuroMab clone N454/91 |
| Anti-ANO5/TMEM16E, NeuroMab clone N421A/85 |
| Anti-ANO6/TMEM16F, NeuroMab clone N429/19 |
| Anti-ARHGAP4, NeuroMab clone N290B/25 |
| Anti-Arl13b, NeuroMab clone N295B/66 |
| Anti-Arx, NeuroMab clone N411/51 |
| Anti-ASIC1, NeuroMab clone N271/44 |
| Anti-ATAT1, NeuroMab clone N347/42 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/8 |
| Anti-Ataxin-1 11NQ, NeuroMab clone N76/3 |
| Anti-Ataxin-1 wild-type, NeuroMab clone N65/37 |
| Anti-ATF4, NeuroMab clone N360A/24 |
| Anti-BAF53a, NeuroMab clone N336B/83 |
| Anti-BAF53b, NeuroMab clone N332B/15 |
| Anti-Bassoon, NeuroMab clone L124/59 |
| Anti-BBS3/Arl6, NeuroMab clone N302/10 |
| Anti-BBS5, NeuroMab clone N304B/115 |
| Anti-BDNF, NeuroMab clone N450/53 |
| Anti-Beta1-spectrin, NeuroMab clone N385/21 |
| Anti-Beta4-spectrin, NeuroMab clone N393/2 |
| Anti-Beta4-spectrin, NeuroMab clone N393/76 |
| Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32 |
| Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18 |
| Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3 |
| Anti-Botch1/Chac1, NeuroMab clone N116/14 |
| Anti-Bral1, NeuroMab clone N364/10 |
| Anti-Bral1, NeuroMab clone N364/42 |
| Anti-Brevican, NeuroMab clone N294A/6 |
| Anti-Brevican, NeuroMab clone N294A/10 |
| Anti-CALB1/calbindin, NeuroMab clone L109/39 |
| Anti-CALB1/calbindin, NeuroMab clone L109/57 |
| Anti-CALB2/calretinin, NeuroMab clone L122/6 |
| Anti-CALB2/calretinin, NeuroMab clone L122/68 |
| Anti-CASK scaffolding protein, NeuroMab clone K56A/50 |
| Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35 |
| Anti-Caspr2/paranodin, NeuroMab clone K67/25 |
| Anti-Cav1.2 calcium channel, NeuroMab clone L57/46 |
| Anti-Cav1.2, NeuroMab clone N263/31 |
| Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9 |
| Anti-Cav1.3 calcium channel, NeuroMab clone N38/8 |
| Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9 |
| Anti-Cav3.2 calcium channel, NeuroMab clone N55/10 |
| Anti-Cav1 calcium channel, NeuroMab clone N7/18 |
| Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1 |
| Anti-Cav3 calcium channel, NeuroMab clone N473/36 |
| Anti-Cav尾4 calcium channel, NeuroMab clone N10/7 |
| Anti-Cdkl5, NeuroMab clone EA7 |
| Anti-CDY1/2, NeuroMab clone N143/38 |
| Anti-CDY1/2/L1/L2, NeuroMab clone N143/36 |
| Anti-Celf4/Brunol4, NeuroMab clone N446/80 |
| Anti-FOS, NeuroMab clone N486/32 |
| Anti-FOS, NeuroMab clone N486/76 |
| Anti-Clcn3, NeuroMab clone N258/5 |
| Anti-Clcn4, NeuroMab clone N222/6 |
| Anti-Clcn5, NeuroMab clone N406/47 |
| Anti-CLN3, NeuroMab clone N380/87 |
| Anti-CLN6, NeuroMab clone N400/24 |
| Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12 |
| Anti-Collybistin, NeuroMab clone L120/12 |
| Anti-Collybistin, NeuroMab clone L120/30 |
| Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20 |
| Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4 |
| Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29 |
| Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8 |
| Anti-DEPDC5, NeuroMab clone N463/52 |
| Anti-Dicer, NeuroMab clone N167/7 |
| Anti-DLX1 transcription factor, NeuroMab clone L43/40 |
| Anti-DNAH1, NeuroMab clone N251/14 |
| Anti-DNAH7, NeuroMab clone N250/21 |
| Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11 |
| Anti-DNMT3L, NeuroMab clone N117/9 |
| Anti-Doc2b, NeuroMab clone N150/21 |
| Anti-Dopamine D2 receptor, NeuroMab clone N186/29 |
| Anti-Dopamine D3 receptor, NeuroMab clone N331/19 |
| Anti-EAAC1, NeuroMab clone N420/24 |
| Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14 |
| Anti-FGF12/FHF1, NeuroMab clone N94/17 |
| Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27 |
| Anti-FGF13B/FHF2B, NeuroMab clone N225A/10 |
| Anti-FGF14/FHF4, NeuroMab clone N56/21 |
| Anti-Fig4/Sac3, NeuroMab clone N202/7 |
| Anti-Flrt3, NeuroMab clone N353/13 |
| Anti-Foxi2, NeuroMab clone N349/96 |
| Anti-Foxi3, NeuroMab clone N359/28 |
| Anti-Frataxin, NeuroMab clone N191/7 |
| Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35 |
| Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19 |
| Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34 |
| Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24 |
| Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32 |
| Anti-GABA-A-R-Beta1, NeuroMab clone N96/55 |
| Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1 |
| Anti-GABA-A-R-Beta3, NeuroMab clone N87/25 |
| Anti-Delta GABA-A receptor, NeuroMab clone N151/3 |
| Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67 |
| Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73 |
| Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30 |
| Anti-GABA-A-R-Pi, NeuroMab clone N431/64 |
| Anti- GABA-A-R-Theta, NeuroMab clone L123/109 |
| Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2 |
| Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37 |
| Anti-GAD65/67, NeuroMab clone L127/12 |
| Anti-GAD67, NeuroMab clone L127/8 |
| Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17 |
| Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30 |
| Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27 |
| Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13 |
| Anti-Gephyrin, NeuroMab clone L106/83 |
| Anti-Gephyrin, NeuroMab clone L106/93 |
| Anti-Gephyrin, NeuroMab clone L106/4 |
| Anti-GFAP, NeuroMab clone N206A/8 |
| Anti-GFAP-R416WT, NeuroMab clone N206B/9 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8 |
| Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/20 |
| Anti-GFP (green fluorescent protein), NeuroMab clone N86/44 |
| Anti-GIT1 scaffold protein, NeuroMab clone N39B/8 |
| Anti-GIT2 scaffold protein, NeuroMab clone N83/48 |
| Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1 |
| Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32 |
| Anti-KA2 kainate receptor, NeuroMab clone N279B/27 |
| Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48 |
| Anti-NR2A glutamate receptor, NeuroMab clone N327A/38 |
| Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20 |
| Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36 |
| Anti-GluN2C/NR2C, NeuroMab clone N422/18 |
| Anti- GluN3A/NR3A, NeuroMab clone N416/40 |
| Anti-Glycine receptor Alpha3, NeuroMab clone N424/45 |
| Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48 |
| Anti-GRK6A/B, NeuroMab clone N142/28 |
| Anti-Gs protein alpha subunit, NeuroMab clone N192/12 |
| Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13 |
| Anti-Haspin/GSG2, NeuroMab clone N128A/2 |
| Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28 |
| Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37 |
| Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28 |
| Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10 |
| Anti-Histone H2A.Z/V, NeuroMab clone N310/21 |
| Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39 |
| Anti-Histone H3.3, NeuroMab clone N158/28 |
| Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12 |
| Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/19 |
| Anti-Histone H3 pThr11, NeuroMab clone N123/48 |
| Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21 |
| Anti-Homer1L, NeuroMab clone L113/27 |
| Anti-Homer1L, NeuroMab clone L113/13 |
| Anti-Homer1, NeuroMab clone L113/130 |
| Anti-ICK, NeuroMab clone N451/73 |
| Anti-Iduna/RNF146, NeuroMab clone N201/35 |
| Anti-INPP4b, NeuroMab clone N171/17 |
| Anti IP3 receptor type 1 NeuroMab clone L24/18 |
| Anti-IRSp53/BAIAP2, NeuroMab clone L117/1 |
| Anti-JIP-2/IB-2, NeuroMab clone N135/37 |
| Anti-JMJD2A, NeuroMab clone N154/32 |
| Anti-KCC2 transporter, NeuroMab clone N1/66 |
| Anti-KCC2 transporter, NeuroMab clone N1/12 |
| Anti-KChIP1 potassium channel, NeuroMab clone K55/7 |
| Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73 |
| Anti-KChIP3 potassium channel, NeuroMab clone K66/38 |
| Anti-KChIP4 K+ channel, NeuroMab clone N423/75 |
| Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26 |
| Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33 |
| Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16 |
| Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12 |
| Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14 |
| Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38 |
| Anti-Kir2.3 potassium channel, NeuroMab clone N25/35 |
| Anti-Kir2.4 potassium channel, NeuroMab clone N465/11 |
| Anti-Kir3.3 potassium channel, NeuroMab clone N455/15 |
| Anti-Kir6.1 potassium channel, NeuroMab clone N366/60 |
| Anti-Kir6.2 potassium channel, NeuroMab clone N363/71 |
| Anti-Kirrel3 short and long, NeuroMab clone N321C/49 |
| Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48 |
| Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78 |
| Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36 |
| Anti-Kv1.3 potassium channel, NeuroMab clone L23/27 |
| Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31 |
| Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5 |
| Anti-Kv1.5 potassium channel, NeuroMab clone K7/45 |
| Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36 |
| Anti-Kv1.7 potassium channel, NeuroMab clone N471/27 |
| Anti-Kv11.3 potassium channel, NeuroMab clone N447/24 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34 |
| Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21 |
| Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25 |
| Anti-Kv2.2 potassium channel, NeuroMab clone K37/89 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60 |
| Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1 |
| Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8 |
| Anti-Kv3.2 potassium channel, NeuroMab clone N410/17 |
| Anti-Kv3.3 potassium channel, NeuroMab clone N375/67 |
| Anti-Kv3.4 potassium channel, NeuroMab clone N72/16 |
| Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4 |
| Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41 |
| Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30 |
| Anti-Kv6.1 potassium channel, NeuroMab clone N474/27 |
| Anti-Kv6.4 potassium channel, NeuroMab clone N458/10 |
| Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10 |
| Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23 |
| Anti-KCNQ4 potassium channel, NeuroMab clone N43/6 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/88 |
| Anti-Kv8.2 potassium channel, NeuroMab clone N448/50 |
| Anti-Kv9.1 potassium channel, NeuroMab clone N461/19 |
| Anti-Kv9.2 potassium channel, NeuroMab clone N460/19 |
| Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40 |
| Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42 |
| Anti-Kv尾2 potassium channel, NeuroMab clone K17/70 |
| Anti-Laforin, NeuroMab clone N84/37 |
| Anti-LAR/PTPRF, NeuroMab clone N165/38 |
| Anti-Lgi1, NeuroMab clone N283/7 |
| Anti-Lhx6.1, NeuroMab clone N228A/16 |
| Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6 |
| Anti-LRP4 (extracellular), NeuroMab clone N207/27 |
| Anti-LRRK1, NeuroMab clone N341/37 |
| Anti-LRRK1, NeuroMab clone N341/12 |
| Anti-LRRK2/Dardarin, NeuroMab clone N241A/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone N231B/34 |
| Anti-LRRK2/Dardarin, NeuroMab clone 8G10 |
| Anti-LRRK2/Dardarin, NeuroMab clone N138/6 |
| Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8 |
| Anti-LRRTM2, NeuroMab clone N209C/35 |
| Anti-LRRTM4, NeuroMab clone N205B/22 |
| Anti-Mad3, NeuroMab clone N129A/6 |
| Anti-Mad3, NeuroMab clone N129/15 |
| Anti-Malin, NeuroMab clone N85/18 |
| Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4 |
| Anti-MAP3K12, NeuroMab clone N377/20 |
| Anti-MAP3K12, NeuroMab clone N377/83 |
| Anti-MECP2, NeuroMab clone N227/21 |
| Anti-MESD, NeuroMab clone N88/12 |
| Anti-MFF, NeuroMab clone N382/14 |
| Anti-MFF (exon 1), NeuroMab clone N382/69 |
| Anti-MGL, NeuroMab clone N90/20 |
| Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3 |
| Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33 |
| Anti-Miro2, NeuroMab clone N384/63 |
| Anti-MiRP4 potassium channel, NeuroMab clone N472/88 |
| Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24 |
| Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5 |
| Anti-MMACHC, NeuroMab clone N230/21 |
| Anti-MMP9 metalloproteinase, NeuroMab clone L51/82 |
| Anti-MOG, NeuroMab clone L94/54 |
| Anti-Mortalin/GRP75, NeuroMab clone N52A/42 |
| Anti-MPP8, NeuroMab clone N119/44 |
| Anti-NALCN, NeuroMab clone N185/7 |
| Anti-Nav1.1 sodium channel, NeuroMab clone K74/71 |
| Anti-Nav1.2 sodium channel, NeuroMab clone K69/3 |
| Anti-Nav1.4 sodium channel, NeuroMab clone N255/38 |
| Anti-Nav1.5 sodium channel, NeuroMab clone N397/19 |
| Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10 |
| Anti-Nav1.7 sodium channel, NeuroMab clone N68/6 |
| Anti-Nav1.8 sodium channel, NeuroMab clone N134/12 |
| Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74 |
| Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68 |
| Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29 |
| Anti-Navbeta4 sodium channel, NeuroMab clone N168/6 |
| Anti-NCKX4, NeuroMab clone N414/25 |
| Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31 |
| Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/1 |
| Anti-Neurexin-1-Beta, NeuroMab clone N170A/26 |
| Anti-Neuroligin-1, NeuroMab clone N97A/31 |
| Anti-Neuroligin-2, NeuroMab clone L107/39 |
| Anti-Neuroligin-3, NeuroMab clone N110/29 |
| Anti-Neuroligin-4*, NeuroMab clone N98/47 |
| Anti-Neuroligin-4*, NeuroMab clone N98/7 |
| Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21 |
| Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36 |
| Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6 |
| Anti-NKCC1, NeuroMab clone N161/20 |
| Anti-NOS1/nNOS, NeuroMab clone L121/25 |
| Anti-NOS1/nNOS, NeuroMab clone L121/42 |
| Anti-Notch1, NeuroMab clone N253/32 |
| Anti-Npas4, NeuroMab clone N408/62 |
| Anti-Npas4, NeuroMab clone N408/79 |
| Anti-Neuropeptide Y, NeuroMab clone L115/13 |
| Anti-NPY2R, NeuroMab clone L119/106 |
| Anti-NrCAM, NeuroMab clone N343/26 |
| Anti-NSD1, NeuroMab clone N312/10 |
| Anti-NSD3, NeuroMab clone N348/82 |
| Anti-OCRL/INPP5b, NeuroMab clone N166A/26 |
| Anti-Olig1, NeuroMab clone N149/25 |
| Anti-Pan-Ankyrin, NeuroMab clone N388A/60 |
| Anti-Pancortin, NeuroMab clone K96/7 |
| Anti-Pan-FHF-A, NeuroMab clone N235/22 |
| Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32 |
| Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5 |
| Anti-Pan-GRK, NeuroMab clone N145/20 |
| Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82 |
| Anti-Pan-Kv potassium channel, NeuroMab clone K40/17 |
| Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73 |
| Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40 |
| Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78 |
| Anti-pan-Neurofascin, NeuroMab clone L11A/41 |
| Anti-Pan-Neurofascin (external), NeuroMab clone A12/18 |
| Anti-Pannexin-2, NeuroMab clone N121A/1 |
| Anti-Pannexin-2, NeuroMab clone N121A/31 |
| Anti-Pan-PTPR, NeuroMab clone N165/43 |
| Anti-Pan-QKI, NeuroMab clone N147/6 |
| Anti-Pan-SAPAP, NeuroMab clone N127/31 |
| Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49 |
| Anti-Pan-Synapsin, NeuroMab clone L125/129 |
| Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63 |
| Anti-PARIS/ZNF746, NeuroMab clone N196/16 |
| Anti-Parvalbumin, NeuroMab clone L114/3 |
| Anti-Parvalbumin, NeuroMab clone L114/81 |
| Anti-PEX6, NeuroMab clone N233/8 |
| Anti-PEX7, NeuroMab clone N232/9 |
| Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25 |
| Anti-Phosphoserine-2-OH, NeuroMab clone N259/48 |
| Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16 |
| Anti-PhyH/PAHX, NeuroMab clone N210/5 |
| Anti-PICK1 scaffold, NeuroMab clone L20/8 |
| Anti-PINK1, NeuroMab clone N4/15 |
| Anti-PINK1, NeuroMab clone N4/49 |
| Anti-PINK1, NeuroMab clone N4/19 |
| Anti-PINK1, NeuroMab clone N357/6 |
| Anti-Proser1, NeuroMab clone N456/39 |
| Anti-Prrt2, NeuroMab clone N485/22 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30 |
| Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43 |
| Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74 |
| Anti-QKI-5-NLS, NeuroMab clone N195A/16 |
| Anti-QKI-6, NeuroMab clone N182/17 |
| Anti-QKI-7, NeuroMab clone N183/15 |
| Anti-QKI-7b, NeuroMab clone N194/11 |
| Anti-RBM17/SPF45, NeuroMab clone N219/5 |
| Anti-REEP, NeuroMab clone N326D/13 |
| Anti-REEP1, NeuroMab clone N345/51 |
| Anti-REEP1/2, NeuroMab clone N326D/29 |
| Anti-REEP2, NeuroMab clone N326D/2 |
| Anti-Rem2, NeuroMab clone N324/2 |
| Anti-RGS14, NeuroMab clone N133/21 |
| Anti-RGS14, NeuroMab clone N133/35 |
| Anti-Rufy3, NeuroMab clone N483/84 |
| Anti-Rufy3, NeuroMab clone N483/126 |
| Anti-Rufy3, NeuroMab clone N483/26 |
| Anti-S100A5, NeuroMab clone N176A/35 |
| Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27 |
| Anti-SALM5/LRFN5, NeuroMab clone N140A/12 |
| Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2 |
| Anti-SAP97 scaffold protein, NeuroMab clone K64/15 |
| Anti-SAPAP1, NeuroMab clone N238/29 |
| Anti-SAPAP1, NeuroMab clone N238/30 |
| Anti-SAPAP1/2, NeuroMab clone N238/31 |
| Anti-SAPAP2, NeuroMab clone N459/84 |
| Anti-SAPAP3, NeuroMab clone L126/93 |
| Anti-SCG10/stathmin-2, NeuroMab clone L5/1 |
| Anti-SH3GL1, NeuroMab clone K51/1 |
| Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21 |
| Anti-Shank1 and Shank3, NeuroMab clone N367/51 |
| Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6 |
| Anti-Shank3 scaffold protein, NeuroMab clone N69/46 |
| Anti-Shank3, NeuroMab clone N367/62 |
| Anti-SK2 potassium channel, NeuroMab clone K78/29 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48 |
| Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60 |
| Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37 |
| Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32 |
| Anti-SST/Somatostatin, NeuroMab clone L111/118 |
| Anti-S-tag, NeuroMab clone N56/9 |
| Anti-Stonin-2, NeuroMab clone N346/9 |
| Anti-SUR1, NeuroMab clone N289/16 |
| Anti-SUR1 and SUR2B, NeuroMab clone N323A/31 |
| Anti-SUR2A, NeuroMab clone N319A/14 |
| Anti-SUR2B, NeuroMab clone N323B/20 |
| Anti-SVOP, NeuroMab clone N356/9 |
| Anti-SVOP, NeuroMab clone N356/23 |
| Anti-Synapsin-III, NeuroMab clone L125/121 |
| Anti-Synaptotagmin-10, NeuroMab clone N269/73 |
| Anti-Synaptotagmin-12, NeuroMab clone N277/7 |
| Anti-Synaptotagmin-3, NeuroMab clone N278/19 |
| Anti-Synaptotagmin-5, NeuroMab clone N274/8 |
| Anti-Synaptotagmin-6, NeuroMab clone N270/47 |
| Anti-Synaptotagmin-7, NeuroMab clone N275/14 |
| Anti-Synaptotagmin-9, NeuroMab clone N276A/15 |
| Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30 |
| Anti-SynCAM4, NeuroMab clone N244/5 |
| Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17 |
| Anti-SynDIG3/Tmem91, NeuroMab clone N160/21 |
| Anti-SynDIG4, NeuroMab clone L102/45 |
| Anti-Tafazzin, NeuroMab clone N173B/13 |
| Anti-TALK1 potassium channel, NeuroMab clone N466/14 |
| Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1 |
| Anti-TARPGamma2/4/8, NeuroMab clone N245/36 |
| Anti-TASK1 potassium channel, NeuroMab clone N374/48 |
| Anti-Tauro-GM2, NeuroMab clone N175/9 |
| Anti-THAP1, NeuroMab clone N325B/65 |
| Anti-THIK-2 potassium channel, NeuroMab clone N468/37 |
| Anti-Thioredoxin, NeuroMab clone N245/44 |
| Anti-Thorase (Atad1), NeuroMab clone N125/10 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13 |
| Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46 |
| Anti- TRAAK potassium channel, NeuroMab clone N445/27 |
| Anti-TRAK1, NeuroMab clone N389/9 |
| Anti-TRAK2, NeuroMab clone N390/43 |
| Anti-TRESK potassium channel, NeuroMab clone N467/1 |
| Anti-TRIP8b (constant), NeuroMab clone N212/7 |
| Anti-TRIP8b (constant), NeuroMab clone N212/17 |
| Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22 |
| Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34 |
| Anti-TRIP8b (exon 4), NeuroMab clone N212/3 |
| Anti-TrpC1 calcium channel, NeuroMab clone 1F1 |
| Anti-TrpC4 calcium channel, NeuroMab clone N77/15 |
| Anti-TrpC5 calcium channel, NeuroMab clone N67/15 |
| Anti-TrpC7 calcium channel, NeuroMab clone N64A/36 |
| Anti-TrpM4, NeuroMab clone L88/86 |
| Anti-TrpM6, NeuroMab clone N470/22 |
| Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25 |
| Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19 |
| Anti-TrpV1, NeuroMab clone N221/17 |
| Anti-TrpV1, NeuroMab clone N221/12 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/4 |
| Anti-TrpV3 cation channel, NeuroMab clone N15/39 |
| Anti-TWIK-2 potassium channel, NeuroMab clone N469/28 |
| Anti-Uncx, NeuroMab clone N155/9 |
| Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38 |
| Anti-VAChT, NeuroMab clone N425/45 |
| Anti-VAPA, NeuroMab clone N479/12 |
| Anti-VAPA, NeuroMab clone N479/22 |
| Anti-VAPA/B, NeuroMab clone N479/107 |
| Anti-VDAC1, NeuroMab clone N152B/23 |
| Anti-Versican, NeuroMab clone N351/23 |
| Anti-Versican, NeuroMab clone N351/24 |
| Anti-VGAT, NeuroMab clone L118/80 |
| Anti-VGAT, NeuroMab clone L118/66 |
| Anti-VGlut1, NeuroMab clone N28/9 |
| Anti-VGlut2, NeuroMab clone N29/29 |
| Anti-VGlut3, NeuroMab clone N34/34 |
| Anti-VIP, NeuroMab clone L108/92 |
| Anti-VMAT1, NeuroMab clone N440/21 |
| Anti-VMAT1, NeuroMab clone N440/61 |
| Anti-Slc18a2/VMAT2, NeuroMab clone N449/73 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21 |
| Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63 |
| Anti-WAVE1/SCAR, NeuroMab clone K91/36 |
| Anti-WNK1, NeuroMab clone N391/68 |
| Anti-WRN, NeuroMab clone N428/12 |
| Zebrafish PSD Marker, NeuroMab clone N286/74 |
| Anti-Zinedin/Striatin-4, NeuroMab clone K88/64 |
| Anti-ZIP3, NeuroMab clone N476/9 |
| Anti-ZNF423, NeuroMab clone N328B/37 |
艾美捷科技代理Arctizymes Technologies品牌酶制剂。
Arctizymes Technologies 是一家专注于酶技术和生物催化的公司，致力于为制药、化工、食品和环境保护等领域提供高效的酶解决方案。Arctizymes Technologies公司提供多种用于不同工业应用的酶制剂，包括水解酶、氧化还原酶、转移酶等；并根据客户需求，提供定制化的酶开发和优化服务。Arctizymes Technologies公司酶制剂应用领域包括：
（1）制药，广泛应用于药物合成、手性化合物制备等；
（2）化工，用于绿色化学工艺，减少环境污染；
（3）食品，用于食品加工、保鲜和品质改良；
（4）环境保护：用于废水处理、生物降解等环保应用。
<<<< " data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Arctizymes Technologies品牌酶制剂"> 艾美捷科技代理Arctizymes Technologies品牌酶制剂
艾美捷科技特约代理Exalpha公司产品。Exalpha位于美国迈阿密，成立20余年来，坚持以切实解决客户需求为导向，提供高品质的产品。
Exalpha was founded over 20 years ago by a group of scientists dedicated to accelerating the pace of discovery in the life science arena by rapidly developing and marketing unique products at the forefront of science.
In order to develop great products, you have to ask the right questions when you start. Where some companies are satisfied with ‘average’, ‘good enough’ or ‘me too’ products, Exalpha only settles for products that answer the pertinent questions. Exalpha continually monitors scientific trends and recent literature, we strive to produce products that answer real needs. Exalpha has a long history of developing uniquely superior products that simply perform well, allowing researchers to focus on the task at hand and not on the quality of a supplier’s products.
产品主要包括：
Buffers and Reagents
Control Antibodies
Control Lysates
Kits
Proteins and Peptides
Primary Antibodies
Secondary Antibodies
Serum
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Exalpha"> Exalpha
艾乐美生物科技有限公司（AllerMAbs Co., Ltd.）成立于2015年，是台湾一家专注于生产高亲和力、高纯度并具有过敏原特异性的嵌合人类IgE单克隆抗体的生物公司。公司创办人团队在科研过程中发现市面上缺乏多样的IgE单克隆抗体，特別是具有过敏原特异性的人IgE 单抗。如果能制备出这种抗体，将有助于IgE 相关领域的研究工作。因此，AllerMAbs公司团队开始思考与研究利用基因克隆动物来制造人类 IgE 抗体的可行性，经过数年的努力于 2014年开发出人类IgE 抗体基因嵌入小鼠，通过杂交瘤技术 (Hybridoma technology)，成功地研制出分泌嵌合人类IgE 单抗的 IgE 杂交瘤与纯化 IgE 抗体。经测试，此种嵌合人类IgE 单抗的物化性质与对免疫细胞的活性，皆与人类IgE 抗体一致，研究成果于2015 年发表在国际学术期刊上。
AllerMAbs的产品解决了目前人类IgE抗体不易制备的问题，让嵌合人类IgE抗体可以成为人类IgE抗体的替代品，并提供一个更稳定、更符合血清IgE检测系统的校正品，让临床血清IgE的检测结果更加准确与可靠。
其利用动物基因转殖技术，将组成人类IgE抗体分子的ε重链(Heavy chain)和κ轻链(Light chain)的编码基因(Encoding genes)，分別嵌入(Knock-in)小鼠胚胎干细胞(Embryonic stem cells, ES cells)的γ1重链和κ轻链基因的位置，接着把胚胎干细胞分別植入孕母鼠体内，并将其带有嵌入基因之成鼠交互配种，最后得到带有人类IgE抗体重链和轻链基因的基因嵌入小鼠(HεκKI mice)，且体内能制造完整的嵌合人类IgE抗体分子。
技术优势
容易制备IgE杂交瘤与IgE单抗
过敏原特异性
良好的亲和力与专一性
高纯度与高稳定性
可结合至嗜碱性粒细胞上的IgE受体与刺激細胞
可大量生产与高浓度制备
非人类血液来源(相较于血清IgE抗体)
适合用作检测用的校正品
" data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="AllerMAbs"> AllerMAbs
艾美捷科技特约代理Enzyme Research Laboratories公司产品。
Enzyme Research Laboratories公司在过去的30年中已生产和销售多种用于基础研究的凝血酶和辅因子。通过不断追求最优质的产品，赢得了信任，Enzyme Research Laboratories通过提供单克隆抗体和多克隆抗体服务于科学研究和临床诊断领域。
For over 30 years Enzyme Research Laboratories has been manufacturing and distributing a variety of enzymes and cofactors used in basic coagulation research. By constantly striving for products of utmost quality, ERL has earned the trust of coagulation research communities worldwide. ERL is dedicated to serving the research and diagnostic communities by offering a complementary line of monoclonal and polyclonal antibodies.
Enzyme Research Laboratories公司的主要产品包括：
Monoclonal
Polyclonal
Paired Antibodies
Snake Venom Protein
PC Activator
Factor X Activator-RVV
Canine Proteins
Murine Proteins
Porcine Proteins
Rabbit Proteins
Rat Proteins
Des-Gla Proteins
按照研究领域细分：
Zymogens
Enzymes
CoFactors
Inhibitors
Human Fibrinogen
产品清单包括：
| Human Coagulation | |||
| 分类 | 产品清单 | 编号 | 规格 |
| Human Coagulation-Zymogens | Human Prothrombin | HP 1002 | 9.0 mg, 90 mg |
| Human Factor VII | HFVII 1007 | 0.1 mg, 1.0 mg | |
| Human Protein C | HPC 1001 | 0.1 mg, 1.0 mg | |
| Human Factor IX | HFIX 1009 | 0.5 mg | |
| Human Factor X | HFX 1010 | 0.8 mg | |
| Human Factor XI | HFXI 1111 | 0.1 mg, 1.0 mg | |
| Human Factor XIII | HFXIII 1313 | 0.25 mg, 1.0 mg | |
| Human Factor XII | HFXII 1212 | 0.5 mg, 1.0 mg | |
| Human Prekallikrein | HPK 1302 | 1.0 mg | |
| Sing. Chain High Molecular Wt. Kininogen | HK 1300 | 1.0 mg | |
| Two Chain High Molecular Wt. Kininogen | 2HK 1301 | 1.0 mg | |
| Human Glu-Plasminogen | HPg 2001 | 1.0 mg | |
| Human Lys-Plasminogen | LPg 2002 | 1.0 mg | |
| Human Coagulation-Enzymes | Human Alpha Thrombin | HT 1002a | 1000 units |
| Human Gamma Thrombin | HGT | 1.0 mg | |
| Human Factor VIIa | HFVIIa | 0.1 mg, 1.0 mg | |
| Human Activated Protein C | APC | 0.1 mg, 1.0 mg | |
| Human Factor IXa Beta | HFIXa 1080 | 0.5 mg | |
| Human Factor Xa | HFXa 1011 | 0.8 mg | |
| Human Factor XIa | HFXIa 1111a | 0.1 mg, 1.0 mg | |
| Human Factor Alpha-XIIa | HFXIIa 1212a | 0.5 mg, 1.0 mg | |
| Human Factor XIIa beta | HFXIIab | 0.1 mg, 1.0 mg | |
| Human Factor XIIIa | HFXIIIa 1314 | 0.25 mg, 1.0 mg | |
| Human Kallikrein | HPKa 1303 | 1.0 mg | |
| Human Plasmin | HPlasmin | 1.0 mg | |
| Human Coagulation-CoFactors | Human Protein S | HPS | 1.0 mg |
| Human Protein Z | HPZ | 0.5 mg | |
| Human Fibronectin | FN | 1.0 mg | |
| Human Coagulation-Inhibitors | Alpha2-Antiplasmin | α2AP | 0.1 mg, 1.0 mg |
| Corn Trypsin Inhibitor | CTI | 1.0 mg | |
| Human Antithrombin | HAT | 1.0 mg | |
| Human Coagulation-Platelets & Plasma Proteins | Human GPIIbIIIa | GP2b3a | 1.0 mg |
| Platelet Factor 4 | PF4 | 0.1 mg | |
| Apolipoprotein | HAPO-H | 0.1 mg | |
| Human Coagulation-Human Fibrinogen | Human Fibrinogen 1, 2, & 3 | FIB 1, FIB 2, FIB 3 | 1.0 gram |
| Peak 1 Fib (XIII free) | P1 FIB | 10.0 mg | |
| Peak 2 Fibrinogen | P2 FIB | 10 mg | |
<<
| Bovine Coagulation | |||
| 分类 | 产品清单 | 编号 | 规格 |
| Bovine Coagulation-Zymogens | Bovine Protein C | BPC 1003 | 1.0 mg |
| Bovine Prothrombin | BP 1004 | 10 mg | |
| Bovine Factor IX | BFIX 1005 | 0.5 mg | |
| Bovine Factor X | BFX 1006 | 1.0 mg | |
| Bovine Plasminogen | BPG | 1.0 mg | |
| Bovine Coagulation-Enzymes | Bovine Activated Protein C | BPCa | 0.1 mg |
| Bovine Alpha-Thrombin | BT 1002a | 1000 units | |
| Bovine Factor IXa Beta | BFIXa 1080 | 0.5 mg | |
| Bovine Factor Xa | BFXa | 1.0 mg | |
| Bovine Factor XIa | BFXIa 11a | 1.0 mg | |
| Bovine Coagulation-CoFactors | Bovine Factor V/Va | BFV/Va | 1.0 mg, 5.0 mg |
| Bovine Coagulation-Inhibitors | Bovine Antithrombin | BAT | 1.0 mg |
| Bovine Coagulation-Platelets & Plasma Proteins | Bovine Fibrinogen, Plasminogen Depleted | BFIB1 | 1.0 gram |
| Antibodies | |||
| 分类 | 产品清单 | 编号 | 规格 |
| Antibodies-Monoclonal | Anti-Human Factor V | Mab HFV | 0.1 mg , 0.5 mg |
| Anti-Human Factor VII | Mab HFVII | 0.1 mg , 0.5 mg | |
| Anti-Human Factor VIII | Mab HFVIII | 0.1 mg , 0.5 mg | |
| Anti-Human Factor VIII | Mab HFVIII-8001 | 0.1 mg , 0.5 mg | |
| Anti-Human Factor VIII | Mab HFVIII-8011 | 0.1 mg , 0.5 mg | |
| Anti-Human Factor VIII | Mab HFVIII-8002 | 0.1 mg , 0.5 mg | |
| Anti-Human Factor VIII | Mab HFVIII-8040 | 0.1 mg , 0.5 mg | |
| Anti-Human Factor IX | Mab HFIX | 0.1 mg , 0.5 mg | |
| Anti-Human Factor IX | Mab HFIX-102 | 0.1 mg , 0.5 mg | |
| Anti-Human Factor IX | Mab HFIX-001 | 0.1 mg , 0.5 mg | |
| Anti-Human Factor X | Mab HFX | 0.1 mg , 0.5 mg | |
| Anti-Human Factor X Light Chain | Mab HFX-LC | 0.1 mg , 0.5 mg | |
| Anti-Human Factor X Heavy Chain | Mab HFX-HC | 0.1 mg , 0.5 mg | |
| Anti-Human Factor XI | Mab HFXI | 0.1 mg , 0.5 mg | |
| Anti-Human Factor XII | Mab HFXII | 0.1 mg , 0.5 mg | |
| Anti-Human Factor XIII | Mab HFXIII | 0.1 mg , 0.5 mg | |
| Anti-Human Antithrombin | Mab HAT | 0.1 mg , 0.5 mg | |
| Anti-Thrombin | Mab IIa | 0.1 mg , 0.5 mg | |
| Anti-Human Prothrombin | Mab HFII | 0.1 mg , 0.5 mg | |
| Anti-Human Protein C | Mab HPC | 0.1 mg , 0.5 mg | |
| Anti-Human Tissue Factor | Mab TFE | 0.1 mg , 0.5 mg | |
| Anti-Human vWF | Mab VWF | 0.1 mg , 0.5 mg | |
| Anti-Human GPIIbIIIa | Mab GP2b3a | 0.1 mg , 0.5 mg | |
| Anti-Plasminogen | Mab HPG-030 | 0.1 mg , 0.5 mg | |
| Anti-Plasminogen | Mab HPG | 0.1 mg , 0.5 mg | |
| Anti-Vitronectin | Mab VN | 0.1 mg , 0.5 mg | |
| Anti-C4 Binding Protein | Mab C4BP | 0.1 mg , 0.5 mg | |
| Anti-PA Kringle 4 | Mab PA K4 | 0.1 mg , 0.5 mg | |
| Anti-PA Kringle 1-4 | Mab PA K1-4 | 0.1 mg , 0.5 mg | |
| Anti-PA Kringle 1-3 | Mab PA K1-3 | 0.1 mg , 0.5 mg | |
| Anti-Human Fibrinogen | Mab FIB | 0.1 mg , 0.5 mg | |
| Anti-Tissue Plasminogen Activator | Mab TPA | 0.1 mg , 0.5 mg | |
| Antibodies-Polyclonal | Sheep, purified IgG | SAFG-IG | 10 mg |
| Sheep, affinity purified, IgG | SAFG-AP | 0.5 mg | |
| Sheep, peroxidase conjugated. IgG | SAFG-HRP | 0.2 mg | |
| Sheep, affinity purified peroxidase conjugated 0.1 mg | SAFG-APHRP | 0.1 mg | |
| sheep, affinity purified IgG | *SARFG-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG | *SARFG-HRP | 0.2 mg | |
| Sheep, purified IgG | *SAFGP-IG | 5 mg | |
| Sheep, peroxidase conjugated IgG | *SAFGP-HRP | 0.2 mg | |
| Sheep, purified IgG | SAFNE-IG | 10 mg | |
| Sheep, peroxidase conjugated. IgG | *SAFNE-HRP | 0.2 mg | |
| sheep, purified IgG | *SAFPA-IG | 10 mg | |
| sheep, affinity purified IgG | *SAFPA-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG | *SAFPA-HRP | 0.2 mg | |
| sheep, purified IgG | SAFII-IG | 10 mg | |
| sheep, affinity purified IgG | SAFII-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG | SAFII -HRP | 0.2 mg | |
| sheep, Prothrombin Fragment-1, affinity purified IgG | SAFII-F1AP | 0.5 mg | |
| sheep, Prothrombin Fragment-2, affinity purified IgG | SAFII-F2AP | 0.5 mg | |
| sheep, purified IgG | SAHT-IG | 10 mg | |
| sheep, affinity purified IgG, (Prothrombin Adsorbed) | SAHT-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG | SAHT-HRP | 0.2 mg | |
| sheep, purified IgG | *SABT-IG | 10 mg | |
| sheep, affinity purified IgG | SABT-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG | *SABT-HRP | 0.2 mg | |
| sheep, purified IgG, 10 mg | *SART-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | *SART-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | *SART-HRP | 0.2 mg | |
| sheep, purified IgG, 10 mg | SAFV-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAFV-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SAFV-HRP | 0.2 mg | |
| sheep, purified IgG, 10 mg | SAFVII-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAFVII-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SAFVII-HRP | 0.2 mg | |
| sheep, affinity purified IgG Fluorescein Conjugate, 0.1 mg | *SAFVII-APFTC | 0.1 mg | |
| sheep, purified IgG, 10 mg | SAF8C-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAF8C-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SAF8C-HRP | 0.2 mg | |
| sheep, affinity purified IgG Fluorescein Conjugate, 0.1 mg | *SAF8C-APFTC | 0.1 mg | |
| sheep, purified IgG, 5 mg | SAC8C-IG | 5mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | *SAC8C-HRP | 0.2 mg | |
| goat, purified IgG, 10 mg | GAFIX-IG | 10 mg | |
| goat, affinity purified IgG, 0.5 mg | GAFIX-AP | 0.5 mg | |
| goat, peroxidase conjugated IgG, 0.2 mg | GAFIX-HRP | 0.2 mg | |
| goat, peroxidase conjugated affinity purified IgG, 0.1 mg | GAFIX-APHRP | 0.1 mg | |
| goat, affinity purified IgG Fluorescein Conjugate, 0.1mg | *GAFIX-APFTC | 0.1 mg | |
| sheep, purified IgG, 10 mg | SAFIX-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAFIX-AP | 0.5 mg | |
| sheep, peroxidase conjugated affinity purified IgG, 0.1 mg | SAFIX-APHRP | 0.1 mg | |
| goat, purified IgG, 10 mg | GAFX-IG | 10 mg | |
| goat, affinity purified IgG, 0.5 mg | GAFX-AP | 0.5 mg | |
| goat, peroxidase conjugated IgG, 0.2 mg | GAFX-HRP | 0.2 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAFX-AP | 0.5 mg | |
| rabbit, peroxidase conjugated IgG, 0.2 mg | RAFX-HRP | 0.2 mg | |
| goat, purified IgG, 5 mg | GAFXI-IG | 5 mg | |
| goat, affinity purified IgG, 0.5 mg | GAFXI-AP | 0.5 mg | |
| goat, peroxidase conjugated IgG, 0.2 mg | GAFXI-HRP | 0.2 mg | |
| sheep, purified IgG, 5.0 mg | SAFXI-IG | 5.0 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAFXI-AP | 0.5 mg | |
| goat, purified IgG, 5 mg | GAFXII-IG | 5 mg | |
| goat, affinity purified IgG, 0.5 mg | GAFXII-AP | 0.5 mg | |
| goat peroxidase conjugated IgG, 0.2 mg | GAFXII-HRP | 0.2 mg | |
| sheep, purified IgG, 10 mg | SAFXIII-IG | 10 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SAFXIII-HRP | 0.2 mg | |
| sheep, purified IgG, 10 mg | SAF13A-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAF13A-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | *SAF13A-HRP | 0.2 mg | |
| sheep, purified IgG, 10 mg | SAPK-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAPK-AP | 0.5 mg | |
| sheep, HRP-AP IgG, 0.1 mg | SAPK-APHRP | 0.1 mg | |
| goat, purified IgG, 5 mg | *GAPC-IG | 0.5 mg | |
| goat, affinity purified IgG, 0.5 mg | GAPC-AP | 0.5 mg | |
| sheep, purified IgG, 10 mg | SAPC-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAPC-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SAPC-HRP | 0.2 mg | |
| goat, purified IgG, 5 mg | GAPS-IG | 5mg | |
| goat, peroxidase conjugated IgG, 0.2 mg | GAPS-HRP | 0.2 mg | |
| sheep, purified IgG, 10 mg | SAPS-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAPS-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SAPS-HRP | 0.2 mg | |
| goat, purified IgG, 5 mg | *GAPG-IG | 0.5 mg | |
| goat, affinity purified IgG, 0.5 mg | *GAPG-AP | 0.5 mg | |
| goat, peroxidase conjugated affinity purified IgG, 0.1 mg | GAPG-APHRP | 0.1mg | |
| sheep, purified IgG, 5 mg | *SAPG-IG | 5 mg | |
| sheep, affinity purified IgG, 0.5 mg | *SAPG-AP | 0.5 mg | |
| sheep, purified IgG, 10 mg | *SAPAI-IG | 10 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SAPAI-HRP | 0.2mg | |
| sheep, affinity purified IgG, 0.5 mg | SATAFI-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SATAFI-HRP | 0.2mg | |
| sheep, purified IgG, 10 mg | *SATPA-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SATPA-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SATPA-HRP | 0.2mg | |
| sheep, purified IgG, 10 mg | *SAAT-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAAT-AP | 0.5 mg | |
| sheep, peroxidase conjugated affinity purified IgG, 0.1 mg | SAAT-APHRP | 0.1mg | |
| goat, purified IgG, 10 mg | *GAAT-IG | 10 mg | |
| goat, affinity purified IgG, 0.5 mg | GAAT-AP | 0.5 mg | |
| goat, purified IgG, 5 mg | *GAHC2-IG | 5 mg | |
| goat, affinity purified IgG, 0.5 mg | GAHC2-AP | 0.5 mg | |
| goat, peroxidase conjugated affinity purified IgG, 0.2 mg | *GAHC2-APHRP | 0.2mg | |
| goat, affinity purified IgG, 0.5 mg | *GAPCI-AP | 0.5 mg | |
| goat, peroxidase conjugated IgG, 0.2 mg | *GAPCI-HRP | 0.2mg | |
| goat, purified IgG, 5 mg | *GA2AP-IG | 5 mg | |
| goat, affinity purified IgG, 0.5 mg | GA2AP-AP | 0.5 mg | |
| goat, peroxidase conjugated IgG, 0.2 mg | GA2AP-HRP | 0.2mg | |
| sheep, purified IgG, 10 mg | SA2AP-IG | 10 mg | |
| sheep, purified IgG, 10 mg | *SA1AT-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | *SA1AT-AP | 0.5 mg | |
| sheep, peroxidase conjugated -affinity purified IgG, 0.1 mg | SA1AT-APHRP | 0.1mg | |
| goat, purified IgG, 10 mg | *GA1AT-IG | 10 mg | |
| goat, affinity purified IgG, 0.5 mg | GA1AT-AP | 0.5 mg | |
| goat, purified IgG, 10 mg | *GAA2M-IG | 10 mg | |
| goat, affinity purified IgG, 0.5 mg | GAA2M-AP | 0.5 mg | |
| goat, peroxidase conjugated-affinity purified IgG, 0.1 mg | *GAA2M-APHRP | 0.1mg | |
| sheep, purified IgG, 10 mg | *SAPF4-IG | 10 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SAPF4-HRP | 0.2mg | |
| goat, purified IgG, 5 mg | *GAB2G-IG | 5 mg | |
| goat, affinity purified IgG, 0.5 mg | GAB2G-AP | 0.5 mg | |
| goat, peroxidase conjugated IgG, 0.2 mg | GAB2G-HRP | 0.2mg | |
| goat, purified IgG, 2.5 mg | GAVWF-IG | 5 mg | |
| goat, affinity purified IgG, 0.5 mg | GAVWF-AP | 0.5 mg | |
| goat, peroxidase conjugated IgG, 0.15 mg | GAVWF-HRP | 0.1mg | |
| sheep, purified IgG, 5 mg | SACWF-IG | 5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SACWF-HRP | 0.2mg | |
| sheep, purified IgG, 5 mg | SARTW-IG | 5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SARTW-HRP | 0.2mg | |
| sheep, purified IgG, 10 mg | SATF-IG | 10 mg | |
| sheep, peroxidase conjugated, 0.2 mg | *SATF-HRP | 0.2mg | |
| mouse, Fluorescein Conjugate, 0.1 mg | MATF-FITC | 0.1mg | |
| sheep, purified IgG, 10 mg | *SATFPI-IG | 10 mg | |
| sheep, purified IgG, 10 mg | *SAVN-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SAVN-AP | 0.5 mg | |
| sheep, peroxidase conjugated affinity purified, 0.1 mg | SAVN-APHRP | 0.1mg | |
| goat, purified IgG, 5 mg | GACINH-IG | 5 mg | |
| goat, affinity purified IgG, 0.5 mg | GACINH-AP | 0.5 mg | |
| goat, peroxidase conjugated IgG, 0.2 mg | GACINH-HRP | 0.2mg | |
| sheep, purified IgG, 10 mg | *SANE-IG | 10 mg | |
| sheep, affinity purified IgG, 0.5 mg | SANE-AP | 0.5 mg | |
| sheep, peroxidase conjugated IgG, 0.2 mg | SANE-HRP | 0.2mg | |
| sheep, purified IgG, 10 mg | SA2B3A-IG | 10 mg | |
| sheep, peroxidase conjugated affinity purified IgG, 0.5 mg | SAR-APHRP | 0.5 mg | |
| -Rabbit non-immune IgG, 10 mg | NIR-IG | 10 mg | |
| -Sheep non-immune IgG, 20 mg | NIS-IG | 20mg | |
| -Sheep non-immune FITC, 0.1 mg | *NIS-FITC | 0.1mg | |
| -Goat non-immune IgG, 10 mg | NIG-IG | 10 mg | |
| donkey, peroxidase conjugated affinity purified IgG, 0.5 mg | DAS-APHRP | 0.5 mg | |
| Antibodies-Paired Antibodies | von Willebrand Factor | VWF-EIA | - |
| Factor V | FV-EIA | - | |
| Factor VII | FVII-EIA | - | |
| Factor VIII:C | FVIII:C-EIA | - | |
| Factor IX | FIX-EIA | - | |
| Factor X | FX-EIA | - | |
| Factor XI | FXI-EIA | - | |
| Factor XII | FXII-EIA | - | |
| Factor XIII | FXIII-EIA | - | |
| Prothrombin | FII-EIA | - | |
| Protein S | PS-EIA | - | |
| Protein C | PC-EIA | - | |
| Alpha 1 Antitrypsin | A1AT-EIA | - | |
| Antithrombin III | ATIII-EIA | - | |
| Thrombin-Antithrombin Complex | TAT-EIA | - | |
| Plasminogen | PG-EIA | - | |
| Tissue Plasminogen Activator | TPA-EIA | - | |
| Fibrinogen | FG-EIA | - | |
| Apolipoprotein-H (B2-Glycoprotein) | APOH-EIA | - | |
| Canine Factor VIII | CFVIII-EIA | - | |
| Canine Factor IX | CFIX-EIA | - | |
| Prekallikrein | PK-EIA | - | |
| Substrates | |||
| 分类 | 产品清单 | 编号 | 规格 |
| Substrates-Substrates | PlasminChrom | 100-01 | 5mg |
| Substrates-Substrates | ThrombinChrom | 100-02 | 5mg |
| Substrates-Substrates | RGR-XaChrom | 100-03 | 5mg |
| Snake Venom Protein | |||
| 分类 | 产品清单 | 编号 | 规格 |
| Snake Venom Protein | Factor X Activator-RVV | RVV-X | 0.1 mg |
| Other Products | ||
| 分类 | 产品清单 | 编号 |
| Other Products-Canine Proteins | Canine Fibrinogen | CFib |
| Canine Thrombin | CIIa | |
| Canine Factor IX | CFIX | |
| Canine Factor X | CFX | |
| Canine Factor Xa | CFXa | |
| Other Products-Murine Proteins | Murine Fibrinogen | MFg |
| Murine Antithrombin III | MAT | |
| Murine Thrombin | MIIa | |
| Murine Factor XIII | MFXIII | |
| Murine Plasminogen | MPg | |
| Other Products-Porcine Proteins | Porcine Factor Xa | PFXa |
| Porcine Thrombin | PIIa | |
| Porcine Fibrinogen | PFib | |
| Other Products-Rabbit Proteins | Rabbit Fibrinogen | RbFg |
| Rabbit Factor Xa | RbXa | |
| Rabbit Factor X | RbX | |
| Rabbit Thrombin | RbIIa | |
| Other Products-Rat Proteins | Rat Fibrinogen | RFib |
| Rat Thrombin | RIIa | |
| Rat Factor Xa | RFXa | |
| Other Products-Des-Gla Proteins | Des-Gla-Human Protein C | HPC-GD |
| Des-Gla-Human Activated Protein C | APC-GD | |
| Des-Gla-Human Factor X | HFX-GD | |
| Des-Gla-Human Factor Xaβ | HFXab-GD | |
| Des-Gla-Human Factor VIIa | HFVIIaGD | |
| Des-Gla-Human Prothrombin | HP-GD | |
| Other Products-Inactivated Proteins | Human Thrombin | HTi |
| Human Factor VIIa | HFVIIai | |
| Human Factor IXaß | HFIXai | |
| Human Activated Protein C | APCi | |
艾美捷科技代理Subangstrom品牌。
Subangstrom是一家专注于为电子显微镜（Electron Microscopy, EM）领域提供高质量样品制备工具和解决方案的公司。公司致力于支持科学家在结构生物学、材料科学和纳米技术等领域的研究，提供从样品制备到数据分析的全流程解决方案。Subangstrom业务领域：
（1）样品制备工具：Subangstrom 提供用于电子显微镜样品制备的工具，如冷冻切片机（Cryo-ultramicrotome）、冷冻传输系统和样品支架。
（2）冷冻电镜耗材：提供用于冷冻电镜研究的耗材，如冷冻网格（Cryo-grids）、冷冻保护剂和样品支架。
（3）自动化样品制备系统：Subangstrom 提供自动化样品制备系统，用于高通量冷冻样品制备和筛选。
（4）冷冻传输系统：提供用于冷冻样品传输的系统，确保样品在制备和观察过程中保持低温状态。这些系统与主流电子显微镜兼容，支持无缝集成和自动化操作。
< " data-original="http://norgen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Subangstrom品牌"> 艾美捷科技代理Subangstrom品牌
艾美捷科技代理Imagion Biosystems公司产品。
Imagion Biosystems公司提供高品质的PrecisionMRX®系列氧化铁(Fe3O4)纳米颗粒。PrecisionMRX®纳米颗粒是具有均匀球形形态、
窄尺寸的超顺磁性氧化铁纳米颗粒，特点是分散性和高磁弛豫性。为了达到最高质量，Imagion Biosystems使用热分解工艺，该工艺可
以精确控制纳米颗粒的尺寸、形状和磁性，并保持最小的批间差异。
Carboxylic Acid Functionalized PrecisionMRX® Nanoparticles
Size：10mg/50mg
Dextran-Coated PrecisionMRX® Nanoparticles
Size：10mg/5mg
mPEG Coated PrecisionMRX® Nanoparticles
Size：10mg/5mg
Oleic Acid Coated PrecisionMRX® Nanoparticles
Size：100mg/50mg
地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：15172431432
传真：18995651644
邮箱：sales@amyjet.com
0.4277
